annual FCF:
$76.98M+$82.20M(+1574.45%)Summary
- As of today (September 14, 2025), LGND annual free cash flow is $76.98 million, with the most recent change of +$82.20 million (+1574.45%) on December 31, 2024.
- During the last 3 years, LGND annual FCF has risen by +$6.94 million (+9.91%).
- LGND annual FCF is now -57.97% below its all-time high of $183.17 million, reached on December 31, 2018.
Performance
LGND Free cash flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly FCF:
$15.58M+$43.13M(+156.56%)Summary
- As of today (September 14, 2025), LGND quarterly free cash flow is $15.58 million, with the most recent change of +$43.13 million (+156.56%) on June 30, 2025.
- Over the past year, LGND quarterly FCF has increased by +$4.46 million (+40.16%).
- LGND quarterly FCF is now -78.84% below its all-time high of $73.64 million, reached on June 30, 2018.
Performance
LGND quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM FCF:
$37.75M+$4.46M(+13.41%)Summary
- As of today (September 14, 2025), LGND TTM free cash flow is $37.75 million, with the most recent change of +$4.46 million (+13.41%) on June 30, 2025.
- Over the past year, LGND TTM FCF has increased by +$46.96 million (+509.95%).
- LGND TTM FCF is now -80.76% below its all-time high of $196.19 million, reached on June 30, 2018.
Performance
LGND TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Free cash flow Formula
FCF = Cash From Operations − CAPEX
LGND Free cash flow Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +1574.5% | +40.2% | +509.9% |
| 3 y3 years | +9.9% | +194.6% | -60.7% |
| 5 y5 years | +341.4% | -36.1% | +36.0% |
LGND Free cash flow Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -35.8% | +1574.5% | -69.7% | +135.7% | -68.5% | +283.2% |
| 5 y | 5-year | -35.8% | +341.4% | -69.7% | +135.7% | -68.5% | +283.2% |
| alltime | all time | -58.0% | +154.9% | -78.8% | +118.5% | -80.8% | +120.1% |
LGND Free cash flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | $15.58M(-156.6%) | $37.75M(+13.4%) |
| Mar 2025 | - | -$27.55M(-199.7%) | $33.29M(-56.8%) |
| Dec 2024 | $76.98M(-1574.4%) | $27.64M(+25.2%) | $76.98M(+1247.9%) |
| Sep 2024 | - | $22.08M(+98.6%) | $5.71M(-162.0%) |
| Jun 2024 | - | $11.12M(-31.1%) | -$9.21M(-55.3%) |
| Mar 2024 | - | $16.14M(-137.0%) | -$20.61M(+294.8%) |
| Dec 2023 | -$5.22M(-104.4%) | -$43.63M(-709.4%) | -$5.22M(-105.8%) |
| Sep 2023 | - | $7.16M(-2611.9%) | $89.75M(-9.1%) |
| Jun 2023 | - | -$285.00K(-100.9%) | $98.75M(-5.3%) |
| Mar 2023 | - | $31.53M(-38.6%) | $104.33M(-13.0%) |
| Dec 2022 | $119.93M(+71.2%) | $51.34M(+217.7%) | $119.93M(+27.5%) |
| Sep 2022 | - | $16.16M(+205.5%) | $94.03M(-2.2%) |
| Jun 2022 | - | $5.29M(-88.8%) | $96.13M(-9.7%) |
| Mar 2022 | - | $47.14M(+85.2%) | $106.42M(+51.9%) |
| Dec 2021 | $70.04M(+39.7%) | $25.45M(+39.4%) | $70.04M(+72.2%) |
| Sep 2021 | - | $18.25M(+17.1%) | $40.67M(+15.7%) |
| Jun 2021 | - | $15.58M(+44.9%) | $35.16M(-20.0%) |
| Mar 2021 | - | $10.75M(-374.3%) | $43.96M(-12.3%) |
| Dec 2020 | $50.13M(-257.2%) | -$3.92M(-130.8%) | $50.13M(+7.3%) |
| Sep 2020 | - | $12.74M(-47.7%) | $46.71M(+68.2%) |
| Jun 2020 | - | $24.38M(+44.1%) | $27.77M(-148.1%) |
| Mar 2020 | - | $16.92M(-330.6%) | -$57.67M(+96.6%) |
| Dec 2019 | -$31.89M(-117.4%) | -$7.34M(+18.4%) | -$29.34M(-402.8%) |
| Sep 2019 | - | -$6.20M(-89.9%) | $9.69M(-77.5%) |
| Jun 2019 | - | -$61.06M(-234.9%) | $42.97M(-75.8%) |
| Mar 2019 | - | $45.26M(+42.8%) | $177.67M(-8.0%) |
| Dec 2018 | $183.17M(+100.4%) | $31.68M(+17.0%) | $193.17M(-1.3%) |
| Sep 2018 | - | $27.08M(-63.2%) | $195.64M(-0.3%) |
| Jun 2018 | - | $73.64M(+21.2%) | $196.19M(+53.5%) |
| Mar 2018 | - | $60.76M(+77.9%) | $127.82M(+40.2%) |
| Dec 2017 | $91.41M(+110.4%) | $34.15M(+23.6%) | $91.19M(+17.0%) |
| Sep 2017 | - | $27.63M(+423.7%) | $77.97M(+14.5%) |
| Jun 2017 | - | $5.28M(-78.1%) | $68.09M(+24.5%) |
| Mar 2017 | - | $24.14M(+15.3%) | $54.72M(+25.9%) |
| Dec 2016 | $43.46M(+19.6%) | $20.93M(+17.8%) | $43.46M(+22.3%) |
| Sep 2016 | - | $17.76M(-319.1%) | $35.53M(+25.9%) |
| Jun 2016 | - | -$8.10M(-162.9%) | $28.21M(-39.1%) |
| Mar 2016 | - | $12.88M(-0.9%) | $46.34M(+14.8%) |
| Dec 2015 | $36.34M(+85.8%) | $13.00M(+24.5%) | $40.37M(+10.3%) |
| Sep 2015 | - | $10.44M(+4.1%) | $36.61M(+22.4%) |
| Jun 2015 | - | $10.03M(+45.2%) | $29.91M(+25.2%) |
| Mar 2015 | - | $6.91M(-25.2%) | $23.89M(+22.2%) |
| Dec 2014 | $19.56M(+16.8%) | $9.24M(+147.4%) | $19.55M(-12.1%) |
| Sep 2014 | - | $3.73M(-6.8%) | $22.23M(+23.3%) |
| Jun 2014 | - | $4.01M(+55.9%) | $18.04M(+4.4%) |
| Mar 2014 | - | $2.57M(-78.4%) | $17.27M(+3.2%) |
| Dec 2013 | $16.74M(-3957.6%) | $11.92M(-2669.0%) | $16.74M(+138.1%) |
| Sep 2013 | - | -$464.00K(-114.3%) | $7.03M(+13.2%) |
| Jun 2013 | - | $3.25M(+59.0%) | $6.21M(+211.5%) |
| Mar 2013 | - | $2.04M(-7.6%) | $2.00M(-559.7%) |
| Dec 2012 | -$434.00K(-65.3%) | $2.21M(-272.4%) | -$434.00K(-109.8%) |
| Sep 2012 | - | -$1.28M(+31.6%) | $4.41M(-2.6%) |
| Jun 2012 | - | -$974.00K(+151.0%) | $4.53M(-277.9%) |
| Mar 2012 | - | -$388.00K(-105.5%) | -$2.54M(+103.5%) |
| Dec 2011 | -$1.25M(-95.6%) | $7.05M(-705.1%) | -$1.25M(-86.8%) |
| Sep 2011 | - | -$1.17M(-85.5%) | -$9.48M(-40.7%) |
| Jun 2011 | - | -$8.04M(-988.0%) | -$15.99M(+57.2%) |
| Mar 2011 | - | $906.00K(-177.3%) | -$10.17M(-62.3%) |
| Dec 2010 | -$28.38M(-17.3%) | -$1.17M(-84.7%) | -$27.01M(-0.4%) |
| Sep 2010 | - | -$7.68M(+245.0%) | -$27.11M(-12.5%) |
| Jun 2010 | - | -$2.23M(-86.0%) | -$30.99M(+19.6%) |
| Mar 2010 | - | -$15.93M(+1150.5%) | -$25.92M(-24.5%) |
| Dec 2009 | -$34.32M | -$1.27M(-89.0%) | -$34.32M(+27.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2009 | - | -$11.56M(-506.4%) | -$26.90M(-6.8%) |
| Jun 2009 | - | $2.84M(-111.7%) | -$28.86M(-19.5%) |
| Mar 2009 | - | -$24.34M(-495.6%) | -$35.86M(+69.8%) |
| Dec 2008 | -$21.12M(-78.5%) | $6.15M(-145.5%) | -$21.12M(-41.5%) |
| Sep 2008 | - | -$13.52M(+224.9%) | -$36.13M(-2.0%) |
| Jun 2008 | - | -$4.16M(-56.6%) | -$36.88M(-40.8%) |
| Mar 2008 | - | -$9.60M(+8.3%) | -$62.33M(-36.5%) |
| Dec 2007 | -$98.17M(-30.0%) | -$8.86M(-37.9%) | -$98.17M(-43.4%) |
| Sep 2007 | - | -$14.27M(-51.8%) | -$173.57M(-7.8%) |
| Jun 2007 | - | -$29.61M(-34.8%) | -$188.24M(+13.7%) |
| Mar 2007 | - | -$45.44M(-46.1%) | -$165.56M(+18.0%) |
| Dec 2006 | -$140.30M(-2532.0%) | -$84.26M(+191.2%) | -$140.30M(+213.2%) |
| Sep 2006 | - | -$28.94M(+317.5%) | -$44.80M(+362.4%) |
| Jun 2006 | - | -$6.93M(-65.6%) | -$9.69M(-13.6%) |
| Mar 2006 | - | -$20.17M(-279.4%) | -$11.21M(-294.3%) |
| Dec 2005 | $5.77M(+168.3%) | $11.25M(+82.3%) | $5.77M(-74.8%) |
| Sep 2005 | - | $6.17M(-173.0%) | $22.93M(+157.6%) |
| Jun 2005 | - | -$8.45M(+164.7%) | $8.90M(+91.8%) |
| Mar 2005 | - | -$3.19M(-111.2%) | $4.64M(+115.9%) |
| Dec 2004 | $2.15M(-132.4%) | $28.41M(-461.4%) | $2.15M(-111.5%) |
| Sep 2004 | - | -$7.86M(-38.2%) | -$18.63M(+31.4%) |
| Jun 2004 | - | -$12.71M(+123.7%) | -$14.17M(-891.3%) |
| Mar 2004 | - | -$5.68M(-174.5%) | $1.79M(-171.4%) |
| Dec 2003 | -$6.64M(-95.1%) | $7.63M(-324.1%) | -$2.51M(-87.4%) |
| Sep 2003 | - | -$3.41M(-204.9%) | -$19.99M(-4.0%) |
| Jun 2003 | - | $3.25M(-132.5%) | -$20.81M(-43.2%) |
| Mar 2003 | - | -$9.98M(+1.4%) | -$36.62M(+29.5%) |
| Dec 2002 | -$134.58M(+515.1%) | -$9.84M(+132.4%) | -$28.27M(+26.5%) |
| Sep 2002 | - | -$4.24M(-66.3%) | -$22.34M(-11.5%) |
| Jun 2002 | - | -$12.56M(+667.7%) | -$25.26M(+165.5%) |
| Mar 2002 | - | -$1.64M(-58.2%) | -$9.51M(-56.5%) |
| Dec 2001 | -$21.88M(-56.3%) | -$3.91M(-45.2%) | -$21.88M(-19.5%) |
| Sep 2001 | - | -$7.15M(-324.3%) | -$27.16M(-24.1%) |
| Jun 2001 | - | $3.19M(-122.7%) | -$35.78M(-25.8%) |
| Mar 2001 | - | -$14.01M(+52.3%) | -$48.26M(-0.4%) |
| Dec 2000 | -$50.11M(-28.9%) | -$9.20M(-41.7%) | -$48.44M(-2.7%) |
| Sep 2000 | - | -$15.77M(+69.8%) | -$49.77M(+1.8%) |
| Jun 2000 | - | -$9.29M(-34.6%) | -$48.91M(-10.4%) |
| Mar 2000 | - | -$14.19M(+34.8%) | -$54.60M(-13.2%) |
| Dec 1999 | -$70.45M(+2.1%) | -$10.52M(-29.4%) | -$62.92M(-10.4%) |
| Sep 1999 | - | -$14.91M(-0.5%) | -$70.24M(-4.3%) |
| Jun 1999 | - | -$14.98M(-33.4%) | -$73.40M(+4.0%) |
| Mar 1999 | - | -$22.51M(+26.2%) | -$70.60M(+2.3%) |
| Dec 1998 | -$69.01M(+291.3%) | -$17.84M(-1.3%) | -$69.01M(+78.0%) |
| Sep 1998 | - | -$18.07M(+48.3%) | -$38.77M(+24.7%) |
| Jun 1998 | - | -$12.18M(-41.8%) | -$31.10M(+2.6%) |
| Mar 1998 | - | -$20.92M(-268.7%) | -$30.32M(+71.3%) |
| Dec 1997 | -$17.64M(-47.7%) | $12.40M(-219.2%) | -$17.70M(-51.2%) |
| Sep 1997 | - | -$10.40M(-8.8%) | -$36.30M(+0.6%) |
| Jun 1997 | - | -$11.40M(+37.3%) | -$36.10M(+8.1%) |
| Mar 1997 | - | -$8.30M(+33.9%) | -$33.40M(-0.9%) |
| Dec 1996 | -$33.70M(-11.4%) | -$6.20M(-39.2%) | -$33.70M(+22.5%) |
| Sep 1996 | - | -$10.20M(+17.2%) | -$27.50M(+59.0%) |
| Jun 1996 | - | -$8.70M(+1.2%) | -$17.30M(+101.2%) |
| Mar 1996 | - | -$8.60M(+168.8%) | -$8.60M(-43.0%) |
| Dec 1995 | -$38.02M(+148.3%) | - | - |
| Mar 1995 | - | -$3.20M(-28.9%) | -$15.10M(+1.3%) |
| Dec 1994 | -$15.31M(+38.7%) | -$4.50M(+45.2%) | -$14.90M(+43.3%) |
| Sep 1994 | - | -$3.10M(-27.9%) | -$10.40M(+42.5%) |
| Jun 1994 | - | -$4.30M(+43.3%) | -$7.30M(+143.3%) |
| Mar 1994 | - | -$3.00M | -$3.00M |
| Dec 1993 | -$11.04M(+4.5%) | - | - |
| Dec 1992 | -$10.56M | - | - |
FAQ
- What is Ligand Pharmaceuticals Incorporated annual free cash flow?
- What is the all time high annual FCF for Ligand Pharmaceuticals Incorporated?
- What is Ligand Pharmaceuticals Incorporated annual FCF year-on-year change?
- What is Ligand Pharmaceuticals Incorporated quarterly free cash flow?
- What is the all time high quarterly FCF for Ligand Pharmaceuticals Incorporated?
- What is Ligand Pharmaceuticals Incorporated quarterly FCF year-on-year change?
- What is Ligand Pharmaceuticals Incorporated TTM free cash flow?
- What is the all time high TTM FCF for Ligand Pharmaceuticals Incorporated?
- What is Ligand Pharmaceuticals Incorporated TTM FCF year-on-year change?
What is Ligand Pharmaceuticals Incorporated annual free cash flow?
The current annual FCF of LGND is $76.98M
What is the all time high annual FCF for Ligand Pharmaceuticals Incorporated?
Ligand Pharmaceuticals Incorporated all-time high annual free cash flow is $183.17M
What is Ligand Pharmaceuticals Incorporated annual FCF year-on-year change?
Over the past year, LGND annual free cash flow has changed by +$82.20M (+1574.45%)
What is Ligand Pharmaceuticals Incorporated quarterly free cash flow?
The current quarterly FCF of LGND is $15.58M
What is the all time high quarterly FCF for Ligand Pharmaceuticals Incorporated?
Ligand Pharmaceuticals Incorporated all-time high quarterly free cash flow is $73.64M
What is Ligand Pharmaceuticals Incorporated quarterly FCF year-on-year change?
Over the past year, LGND quarterly free cash flow has changed by +$4.46M (+40.16%)
What is Ligand Pharmaceuticals Incorporated TTM free cash flow?
The current TTM FCF of LGND is $37.75M
What is the all time high TTM FCF for Ligand Pharmaceuticals Incorporated?
Ligand Pharmaceuticals Incorporated all-time high TTM free cash flow is $196.19M
What is Ligand Pharmaceuticals Incorporated TTM FCF year-on-year change?
Over the past year, LGND TTM free cash flow has changed by +$46.96M (+509.95%)